Revolution Medicines (RVMD) closed an underwritten offering of 16.6 million shares at $46 apiece to certain investors for gross proceeds of $862.5 million.
The offering included prefunded warrants to purchase 2.17 million shares at $45.9999 apiece, the company said Thursday in a statement.
Revolution offered all shares and warrants in the sale.